Off-the-shelf cancer vaccines
US12391736B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 25, 2019 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Sep 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to peptide comprising two or more tumor specific neo open-reading-frame peptides (NOPs), and isolated nucleic acids encoding such peptides, and the uses of these peptides and/or isolated nucleic acids to produce cancer vaccines and the like. With the present invention it becomes possible to provide off-the-shelf cancer vaccines and the like within a short period of time and for potentially 30% of the total population of patients suffering from cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.